Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Journal of Diabetes and Its Complications|July 2, 2013
Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?Cyrus V DesouzaClinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Pioglitazone in the treatment of type 2 diabetes: safety and efficacy reviewCyrus V Desouza, Vijay ShivaswamyPrimary Care Diabetes|October 16, 2010
The effect of group clinics in the control of diabetesCyrus V Desouza, Lindsey Rentschler, Gleb HaynatzkiClinical Therapeutics|March 11, 2015
Cardiometabolic Effects of a New Class of Antidiabetic AgentsCyrus V Desouza, Namita Gupta, Anery PatelDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetesCyrus V Desouza, Lindsey Rentschler, Vivian FonsecaAtherosclerosis|June 9, 2005
Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty ratsCyrus V Desouza, Moira Gerety, Frederick G HamelVascular Pharmacology|June 13, 2009
Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cellsCyrus V Desouza, Moira Gerety, Frederick G HamelJournal of Clinical Medicine|January 28, 2026
Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight LossGunjan Arora, Katherine R Conde, Cyrus V DesouzaVascular Pharmacology|December 5, 2006
Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant ratsCyrus V Desouza, Moira Gerety, Frederick G HamelThe Journal of Clinical Endocrinology and Metabolism|June 1, 2023
Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or FructosamineCyrus V Desouza, Julio Rosenstock, Takuji Kohzuma, et al.Pageof 5